Glaukos (GKOS) Income from Non-Controlling Interests (2014 - 2015)
Glaukos (GKOS) posted quarterly Income from Non-Controlling Interests of -$584000.0 for Q2 2015, down 39.05% year-over-year from -$958125.0 in Q2 2014, and down 17.74% quarter-over-quarter from -$496000.0 in Q1 2015.
Glaukos (GKOS) Income from Non-Controlling Interests (2014 - 2015) Analysis & Trends
Glaukos (GKOS) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$584000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Income from Non-Controlling Interests fell 39.05% year-over-year to -$584000.0; the TTM figure through Dec 2015 stood at -$1.1 million (changed N/A YoY), while the FY2023 annual figure was $4.3 million, down 0.85% from the prior year.
- Income from Non-Controlling Interests slipped to -$584000.0 in Q2 2015 per GKOS's latest filing, from -$496000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$420000.0 in Q2 2014 and bottomed at -$647000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 900,000.00 |
| 10 | Glaukos | 10.92 Bn | 10.80 Bn | 151.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -584,000.00 |
| Mar 31, 2015 | -496,000.00 |
| Dec 31, 2014 | -647,000.00 |
| Sep 30, 2014 | -482,000.00 |
| Jun 30, 2014 | -420,000.00 |